Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
Associated LEGN transcripts
LEGN similar filings
Filing view
External links
Exhibit 15.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Post-Effective Amendment No. 1 to the Registration Statement (Form S-8 No. 333-239478) pertaining to the Share Option Scheme and the 2020 Restricted Shares Plan of Legend Biotech Corporation of our report dated April 2, 2021, with respect to the consolidated financial statements of Legend Biotech Corporation included in this Annual Report (Form 20-F) for the year ended December 31, 2020.
/s/ Ernst & Young Hua Ming LLP |
Shanghai, the People’s Republic of China |
April 2, 2021 |